KATY MINGA: Open Payments
NPI 1609271576 · OXFORD, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,848 in 122 payments from 17 companies in 2025. Trend: 2023 $2,716 · 2024 $2,193 · 2025 $2,848
Food & beverage: $2,793Education: $55
| Company | Payments | Amount |
|---|---|---|
| Inspire Medical Systems, Inc. | 11 | $463 |
| AstraZeneca Pharmaceuticals LP | 13 | $346 |
| Viatris Specialty LLC | 13 | $296 |
| GlaxoSmithKline, LLC. | 16 | $260 |
| HARMONY BIOSCIENCES LLC | 8 | $256 |
| Regeneron Healthcare Solutions, Inc. | 8 | $231 |
| GENZYME CORPORATION | 9 | $225 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 12 | $199 |
| Verona Pharma, Inc. | 9 | $144 |
| Actelion Pharmaceuticals US, Inc. | 8 | $138 |
Products named: INSPIRE, DUPIXENT, YUPELRI, AIRSUPRA, WAKIX, NUCALA, Ohtuvayre, GLASSIA.
Industry payments across MS — which companies pay providers there.
